Use and effectiveness of performance-enhancing substances

Journal of Pharmacy Practice

Volumn 16, Issue 1, 2003, Pages 22-36

  Boyce, Eric G ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Ergogenic aids; Performance enhancing drugs; Sports pharmacy; Training

Indexed keywords

AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; ANDROGEN; ANDROSTENEDIOL; ANDROSTENEDIONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CREATINE; DANAZOL; DIHYDROANDROSTENEDIONE; ESTR 4 ENE 3,17 DIONE; GROWTH HORMONE; HORMONE PRECURSOR; METANDIENONE; METHYLTESTOSTERONE; NANDROLONE; NANDROLONE DECANOATE; NORANDROSTENEDIOL; OXANDROLONE; OXYMETHOLONE; PRASTERONE; RECOMBINANT ERYTHROPOIETIN; STANOZOLOL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADOLESCENT; ATHLETE; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOPING; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH HAZARD; HEALTH PRACTITIONER; HIGH SCHOOL; HUMAN; MALE; MALNUTRITION; PERFORMANCE; PHARMACIST; PHYSICAL DISABILITY; PROTEIN INTAKE; REVIEW; SIDE EFFECT; SPORTS MEDICINE; TRAINING;

EID: 0037310103     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190002239630     Document Type: Review

References (136)

1. Sheppard HL, Raichada SM, Kouri KM, Stenson-Bar-Maor L, Branch JD. Use of creatine and other supplements by members of civilian and military health clubs: a cross-sectional survey. Int J Sport Nutr Exerc Metab. 2000;10:245-259.
2. Delbeke FT, Desmet N, Debackere M. The abuse of doping agents in competing body builders in Flanders (1988-1993). Int J Sports Med. 1995;16:66-70.
3. Keith RE, Stone MH, Carson RE, Lefavi RG, Fleck SJ. Nutritional status and lipid profiles of trained steroid-using bodybuilders. Int J Sport Nutr. 1996;6:247-254.
4. Kamber M, Baume N, Saugy M, Rivier L. Nutritional supplements as a source for positive doping cases? Int J Sport Nutr Exerc Metab. 2001;11:258-263.
5. Catlin DH, Leder BZ, Ahrens B, et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000;284:2618-2621.
6. Silver MD. Use of ergogenic aids by athletes. J Am Acad Orthop Surg. 2001;9:61-70.
7. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. 6th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2000.
8. Hoberman JM, Yesalis CE. The history of synthetic testosterone. Sci Am. 1995;272:76-81.
9. Auge WK II, Auge SM. Naturalistic observation of athletic drug-use patterns and behavior in professional-caliber bodybuilders. Subst Use Misuse. 1999;34:217-249.
10. Ferenchick GS. Validity of self-report in identifying anabolic steroid use among weightlifters. J Gen Intern Med. 1996;11:554-556.
11. Curry LA, Wagman DF. Qualitative description of the prevalence and use of anabolic-androgenic steroids by United States powerlifters. Percept Mot Skills. 1999;88(1):224-233.
12. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001;70:137-140.
13. Wichstrom L, Pedersen W. Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad? J Stud Alcohol. 2001;62:5-13.
14. Bolding G, Sherr L, Maguire M, Elford J. HIV risk behaviors among gay men who use anabolic steroids. Addiction. 1999;94:1829-1835.
15. Bahrke MS, Yesalis CE, Brower KJ. Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. Child Adolesc Psychiatr Clin N Am. 1998;7:821-838.
16. Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol. 1995;48:9-11.
17. Tanner SM, Miller DW, Alongi C. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks. Clin J Sport Med. 1995;5:108-115.
18. DuRant RH, Escobedo LG, Heath GW. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics. 1995;96(1 Pt 1):23-28.
19. Yesalis CE, Bahrke MS. Doping among adolescent athletes. Best Pract Res Clin Endocrinol Metab. 2000;14:25-35.
20. Faigenbaum AD, Zaichkowsky LD, Gardner DE, Micheli LJ. Anabolic steroid use by male and female middle school students. Pediatrics. 1998;101:E6.
21. Drewnowski A, Kurth CL, Krahn DD. Effects of body image on dieting, exercise, and anabolic steroid use in adolescent males. Int J Eat Disord. 1995;17:381-386.
22. Stilger VG, Yesalis CE. Anabolic-androgenic steroid use among high school football players. J Community Health. 1999;24:131-145.
23. Bahrke MS, Yesalis CE, Kopstein AN, Stephens JA. Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Med. 2000;29:397-405.
24. Middleman AB, Faulkner AH, Woods ER, Emans SJ, DuRant RH. High-risk behaviors among high school students in Massachusetts who use anabolic steroids. Pediatrics. 1995;96(2 Pt 1):268-272.
25. Lovstakken K, Peterson L, Homer AL. Risk factors for anabolic steroid use in college students and the role of expectancy. Addict Behav. 1999;24:425-430.
26. O'Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic-androgenic steroids: medical assessment of present, past and potential users. Med J Aust. 2000;173:323-327.
27. Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol. 2000;113:25-29.
28. Kadi F, Eriksson A, Holmner S, Thornell LE. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc. 1999;31:1528-1534.
29. Teruel JL, Marcen R, Navarro JF, et al. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron. 1995;70:282-286.
30. Geusens P. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis. Clin Rheumatol. 1995;14(suppl 3):32-39.
31. Alen M, Hakkinen K, Komi PV. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids. Acta Physiol Scand. 1984;122:535-544.
32. Hartgens F, Van Marken Lichtenbelt WD, Ebbing S, Vollaard N, Rietjens G, Kuipers H. Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration. Int J Sports Med. 2001;22:235-241.
33. Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341-355.
34. Kouri EM, Pope HG, Katz DL, Oliva P. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med. 1995;5:223-228.
35. Yeater R, Reed C, Ullrich I, Morise A, Borsch M. Resistance trained athletes using or not using anabolic steroids compared to runners: effects on cardiorespiratory variables, body composition, and plasma lipids. Br J Sports Med. 1996;30(1):11-14.
36. Kadi F, Eriksson A, Holmner S, Thornell L-E. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc. 1999;31:1528-1534.
37. Bond AJ, Choi PY, Pope HG. Assessment of attentional bias and mood in users and non-users of anabolic-androgenic steroids. Drug Alcohol Depend. 1995;37:241-245.
38. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1-7.
39. Lambert CP, Sullivan DH, Freeling SA, Lindquist DM, Evans WJ. Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin Endocrin Metab. 2002;87:2100-2106.
40. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000;57:141-147.
41. Grinspoon S, Corcoran C, Parlman K, et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: a randomized, controlled trial. Ann Intern Med. 2000;133:348-355.
42. Fox-Wheeler S, Heller L, Salata CM, et al. Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients. Pediatrics. 1999;104:e73.
43. Strawford A, Barbieri T, Van Loan M, et al. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA. 1999;281:1282-1290.
44. Demling RH. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns. 1999;25:215-221.
45. Mendenhall CL, Moritz TE, Roselle GA, et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. J Parenter Enteral Nutr. 1995;19:258-265.
46. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998;114:19-28.
47. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1268-1274.
48. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999;281:1275-1281.
49. Darnton SJ, Zgainski B, Grenier I, et al. The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus. 1999;12:283-288.
50. Fenichel GM, Griggs RC, Kissel J, et al. A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology. 2001;56:1075-1079.
51. Spungen AM, Grimm DR, Strakhan M, Pizzolate PM, Bauman WA. Treatment with an anabolic agent is associated with improvement in respiratory function in persons with tetraplegia: a pilot study. Mount Sinai J Med. 1999;66:201-205.
52. Lamer DS, Martin M. Unusual recovery rate of sartorius avulsion fracture in an athlete abusing anabolic steroids. Athlet Ther Today. 2002;7:45-47.
53. Uralets VP, Gillette PA. Over-the-counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3beta,17beta-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men. J Anal Toxicol. 1999;23:357-366.
54. Corrigan B. DHEA and sport. Clin J Sport Med 2002;12:236-241.
55. Khorram O. Potential therapeutic effects of prescribed and over-the-counter androgens in women. Clin Obstet Gynecol. 2001;44:880-892.
56. Leder BZ, Catlin DH, Longcope C, Ahrens B, Schoenfeld DA, Finkelstein JS. Metabolism of orally administered androstenedione in young men. J Clin Endocrinol Metab. 2001;86:3654-3658.
57. Rasmussen BB, Volpi E, Gore DC, Wolfe RR. Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab. 2000;85:55-59.
58. King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020-2028.
59. Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in high-intensity resistance training program. Arch Intern Med. 2000;160:3093-3104.
60. Mahesh VB, Greenblatt RB. The in vivo conversion of dehydroepiandosterone and androstenedione to testosterone in the human. Acta Endocrinol. 1962;41:400-406.
61. Wallace MB, Lim J, Cutler A, Bucci L. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788-1792.
62. Van Gammeren D, Falk D, Antonio J. The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol on body composition and athletic performance in previously weight-trained male athletes. Eur J Appl Physiol. 2001;84:426-431.
63. Dean H. Does exogenous growth hormone improve athletic performance? Clin J Sport Med. 2002;12:250-253.
64. Rogol AD. Sex steroid and growth hormone supplementation to enhance performance in adolescent athletes. Curr Opin Pediatr. 2000;12:382-387.
65. Karila T, Koistinen H, Seppälä M, Koistinen R, Seppälä T. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes. Clin Endocrin. 1998;49:459-463.
66. De Palo EF, Gatti R, Lancerin F, Cappellin E, Spinella P. Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes. Clin Chim Acta. 2001;305:1-17.
67. Hurel SJ, Koppiker N, Newkirk J, et al. Relationship of physical exercise and aging to growth hormone production. Clin Endocrin. 1999;51:687-691.
68. Lange KHW, Andersen JL, Beyer N, et al. GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance training in healthy elderly men. J Clin Endocrin Metab. 2002;87:515-523.
69. Hütler M, Schnabel D, Staab D, et al. Effect of growth hormone on exercise tolerance in children with cystic fibrosis. Med Sci Sports Exerc. 2002;34:567-572.
70. Parisotto R, Gore CJ, Hahn AG, et al. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes. Int J Sports Med. 2000;21:471-479.
71. Gledhill N, Warburton D, Jamnik V. Haemoglobin, blood volume, cardiac function, and aerobic power. Can J Appl Physiol. 1999;24:54-65.
72. Nissenson AR, Swan SK, Lindberg JS, et al. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis. 2002;40:110-118.
73. Corrigan B. Beyond EPO. Clin J Sport Med. 2002;12:242-244.
74. Sawka MN, Joyner MJ, Miles DS, Robertson RJ, Spriet LL, Young AJ. ACSM position stand: the use of blood doping as an ergogenic aid. Med Sci Sports Exerc. 1996;28:127-134.
75. Warburton DER, Gledhill N, Quinney HA. Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading. Clin J Sport Med. 2000;10:59-66.
76. Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallén J, Hang E, Bahr R. Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc. 2000;32:1238-1243.
77. Demant TW, Rhodes EC. Effects of creatine supplementation on exercise performance. Sports Med. 1999;28:49-60.
78. Bermon S, Venembre P, Sachet C, Valour S, Dolisi C. Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. Acta Physiol Scand. 1998;164:147-155.
79. Harris RC, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci. 1992;83:367-374.
80. Metzl JD, Small E, Levine SR, Gershel JC. Creatine use among young athletes. Pediatrics. 2001;108:421-425.
81. Ray TR, Eck JC, Covington LA, Murphy RB, Williams R, Knudtson J. Use of oral creatine as an ergogenic aid for increased sports performance: perceptions of adolescent athletes. South Med J. 2001;94:608-612.
82. Green AL, Simpson EJ, Littlewood JJ, Macdonald IA, Greenhaff PL. Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol Scand. 1996;158:195-202.
83. Willott CA, Young ME, Leighton B, et al. Creatine uptake in isolated soleus muscle: kinetics and dependence on sodium, but not on insulin. Acta Physiol Scand. 1999;166:99-104.
84. Bellinger BM, Bold A, Wilson GR, Noakes TD, Myburgh KH. Oral creatine supplementation decreases plasma markers of adenine nucleotide degradation during a 1-h cycle test. Acta Physiol Scand. 2000;170:217-224.
85. Kreis R, Kamber M, Koster M, et al. Creatine supplementation-part II: in vivo magnetic resonance spectroscopy. Med Sci Sports Exerc. 1999;31:1770-1777.
86. Odland LM, MacDougall JD, Tarnopolsky MA, Elorriaga A, Borgmann A. Effect of oral creatine supplementation on muscle [PCr] and short-term maximum power output. Med Sci Sports Exerc. 1997;29:216-219.
87. Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol. 1996;81:232-237.
88. Rico-Sanz J, Mendez Marco MT. Creatine enhances oxygen uptake and performance during alternating intensity exercise. Med Sci Sports Exerc. 2000;32:379-385.
89. Op 'T Eijnde B, Richter EA, Henquin JC, Kiens B, Hespel P. Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol Scand. 2001;171:169-176.
90. Tarnopolsky MA, MacLennan DP. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab. 2000;10:452-463.
91. Hamilton KL, Meyers MC, Skelly WA, Marley RJ. Oral creatine supplementation and upper extremity anaerobic response in females. Int J Sport Nutr Exerc Metab. 2000;10:277-289.
92. Cox G, Mujika I, Tumilty D, Burke L. Acute creatine supplementation and performance during a field test simulating match play in elite female soccer players. Int J Sport Nutr Exerc Metab. 2002;12:33-46.
93. Izquierdo M, Ibañez J, González-Badillo JJ, Gorostiaga EM. Effects of creatine supplementation on muscle power, endurance, and sprint performance. Med Sci Sports Exerc. 2002;34:332-343.
94. Leenders N, Sherman WM, Lamb DR, Nelson TE. Creatine supplementation and swimming performance. Int J Sport Nutr. 1999;9:251-262.
95. Burke DG, Chilibeck PD, Davison KS, Candow DG, Farthing J, Smith-Palmer T. The effect of whey protein supplementation with and without creatine monohydrate combined with resistance training on lean tissue mass and muscle strength. Int J Sport Nutr Exerc Metab. 2001;11:349-364.
96. Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146-165.
97. Syrotuik DG, Game AB, Gillies EM, Bell GJ. Effects of creatine monohydrate supplementation during combined strength and high intensity rowing training on performance. Can J Appl Physiol. 2001;26:527-542.
98. Burke DG, Silver S, Holt LE, Smith-Palmer T, Culligan CJ, Chilibeck PD. The effect of continuous low dose creatine supplementation on force, power, and total work. Int J Sport Nutr Exerc Metab. 2000;10:235-244.
99. Vandenberghe K, Gillis N, Van Leemputte M, Van Hecke P, Vanstapel F, Hespel P. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol. 1996;80:452-457.
100. McKenzie DC, Stewart IB, Fitch KD. The asthmatic athlete, inhaled beta agonists, and performance. Clin J Sport Med. 2002;12:225-228.
101. Berges R, Segura J, Ventura R, et al. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin Chem. 2000;46:1365-1375.
102. Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. Respir Med. 2001;95:571-576.
103. Stewart IB, Labreche JM, McKenzie DC. Acute formoterol administration has no ergogenic effect in nonasthmatic athletes. Med Sci Sports Exerc. 2002;34:213-217.
104. van Baak MA, Mayer LHJ, Kempinski RES, Hartgens F. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc. 2000;32:1300-1306.
105. Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. Neurology. 1998;50:1402-1406.
106. Green GA, Uryasz FD, Petr TA, Bray CD. NCAA study of substance use and abuse habits of college-student athletes. Clin J Sport Med. 2001;11:51-56.
107. Bouchard R, Weber AR, Geiger JD. Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med. 2002;12:209-224.
108. Armstrong LE. Caffeine, body fluid-electrolyte balance, and exercise performance. Int J Sport Nutr Exerc Metab. 2002;12:189-206.
109. Laurent D, Schneider KE, Prusaczyk WK, et al. Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrin Metab. 2000;85:2170-2175.
110. Costill DL, Dalsky GP, Fink WJ. Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports. 1978;10:155-158.
111. Ivy JL, Costill DL, Fink WJ, Lower RW. Influence of caffeine and carbohydrate feedings on endurance performance. Med Sci Sports. 1979;11:6-11.
112. Vergauwen L, Brouns F, Hespel P. Carbohydrate supplementation improves stroke performance in tennis. Med Sci Sports Exerc. 1998;30:1289-1295.
113. Bruce CR, Anderson ME, Fraser SF, et al. Enhancement of 2000-m rowing performance after caffeine ingestion. Med Sci Sports Exerc. 2000;32:1958-1963.
114. Anderson ME, Bruce CR, Fraser SF, et al. Improved 2000-meter rowing performance in competitive oarswomen after caffeine ingestion. Int J Sport Nutr Exerc Metab. 2000;10:464-475.
115. Paton CD, Hopkins WG, Vollebregt L. Little effect of caffeine ingestion on repeated springs in team-sport athletes. Med Sci Sports Exerc. 2001;33:822-825.
116. van Baak MA, Peters C, Herpers J, Saris W. The effect of caffeine on endurance performance after non-selective beta-blocker administration [abstract]. Med Sci Sports Exerc. 1996;28(suppl):154.
117. Kruse P, Ladefoged J, Nielsen U, Paulev PE, Sorensen JP. Beta-blockade used in precision sports: effect on pistol shooting performance. J Appl Physiol. 1986;61:417-420.
118. Aarsland A, Chinkes D, Wolfe RR, et al. Beta-blockage lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg. 1996;223:777-789.
119. Saris WHM. Functional foods for athletes [editorial]. Curr Opin Clin Nutr Metab Care. 1999;2:511-513.
120. Parkin JAM, Carey MF, Martin IK, Stojanovska L, Febbraio MA. Muscle glycogen storage following prolonged exercise: effect of timing of ingestion of high glycemic index food. Med Sci Sports Exerc. 1997;29:220-224.
121. Sparks MJ, Selig SS, Febbraio MA. Pre-exercise carbohydrate ingestion: effect of the glycemic index on endurance exercise performance. Med Sci Sports Exerc. 1998;30:844-849.
122. Wee SL, Williams C, Gray S, Horabin J. Influence of high and low glycemic index meals on endurance running capacity. Med Sci Sports Exerc. 1999;31:393-399.
123. Biolo G, Tipton KD, Klein S, Wolfe RR. An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein. Am J Physiol. 1997;273(1 Pt 1):E122-E129.
124. Parise G, Yarasheski KE. The utility of resistance exercise training and amino acid supplementation for reversing age-associated decrements in muscle protein mass and function. Curr Opin Clin Nutr Metab Care. 2000;3:489-495.
125. Vukovich MD, Sharp RL, Kesl LD, Schaulis DL, King DS. Effects of a low-dose amino acid supplement on adaptations to cycling training in untrained individuals. Int J Sport Nutr. 1997;7:298-309.
126. Jentjens RL, van Loon LJ, Mann CH, Wagenmakers AJ, Jeukendrup AE. Addition of protein and amino acids to carbohydrates does not enhance postexercise muscle glycogen synthesis. J Appl Physiol. 2001;91:839-846.
127. Williams MH. Facts and fallacies of purported ergogenic amino acid supplements. Clin Sports Med. 1999;18:633-649.
128. Hargreaves MH, Snow R. Amino acids and endurance exercise. Int J Sport Nutr Exerc Metab. 2001;11:133-145.
129. Panton LB, Rathmacher JA, Baier S, Nissen S. Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB) during resistance training. Nutrition. 2000;16:734-739.
130. Gallagher PM, Carrithers JA, Godard MP, Schulze KE, Trappe SW. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000;32:2109-2115.
131. Campbell WW, Barton ML, Cyr-Campbell D, et al. Effects of an omnivorous diet compared to a lactoovovegetarian diet on resistance-training-induced changes in body composition and skeletal muscle in older men. Am J Clin Nutr. 1999;70:1032-1039.
132. Okano G, Sato Y, Murata Y. Effect of elevated blood FFA levels on endurance performance after a single fat meal ingestion. Med Sci Sports Exerc. 1998;30:763-768.
133. Helge JW. Adaptation to a fat-rich diet: effects on endurance performance in humans. Sports Med. 2000;30:347-357.
134. Price KO, Huff PS, Isetts BJ, Goldwire MA. Univeristy-based sports pharmacy program. Am J Hosp Pharm. 1995;52:302-309.
135. Tricker R, Connolly D. Drug education and the college athlete: evaluation of a decision-making model. J Drug Educ. 1996;26:159-181.
136. Street C, Serrano E, Antonio J. Selective [beta]-2 agonist abuse and polypharmacy in competitive bodybuilding-a case study [abstract]. Med Sci Sports Exerc. 1999;31(suppl):S120.